Vest Financial’s Medifast MED Stock Holding History

Vest Financial’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,452	Closed	-$232K	–	284
2023 Q4	$232K	Buy	+3,452	New	+$240K	0.01%	197

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Vest Financial's MED Position: Q1 2024 in Review

Vest Financial sold out of Medifast (MED) in Q1 2024, closing a stake of 3,452 shares — an estimated $232K sold.

Vest Financial first reported a position in MED in Q4 2023 and held it in 1 quarter. The position peaked at $232K in Q4 2023. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

Vest Financial reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
Vest Financial sold 3,452 Medifast shares in Q1 2024, an estimated $232K.
Vest Financial first reported a position in Medifast in Q4 2023 and held it in 1 quarter.
Vest Financial's Medifast position peaked at $232K in Q4 2023.
186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Vest Financial's 13F filing for Q1 2024, filed 30 Apr 2024.